Co-Diagnostics, Inc. (CODX)
3.00
+0.17
(+6.01%)
USD |
OTCM |
Jan 20, 16:00
Co-Diagnostics EPS Diluted (Quarterly): -4.661 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bionano Genomics, Inc. | -1.593 |
| CareDx, Inc. | 0.0312 |
| Intellia Therapeutics, Inc. | -0.9196 |
| Twist Bioscience Corp. | -0.4491 |
| Pulmonx Corp. | -0.3409 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.887M |
| Revenue (Quarterly) | 0.1454M |
| Total Expenses (Quarterly) | 6.032M |
| Enterprise Value | -3.882M |
| Gross Profit Margin (Quarterly) | -102.0% |
| Profit Margin (Quarterly) | -4.05K% |
| Earnings Yield | -730.4% |
| Normalized Earnings Yield | -730.42 |